Trust Point Inc. Repligen Corp Transaction History
Trust Point Inc.
- $1.06 Trillion
- Q2 2025
A detailed history of Trust Point Inc. transactions in Repligen Corp stock. As of the latest transaction made, Trust Point Inc. holds 2,373 shares of RGEN stock, worth $352,936. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,373
Previous 3,756
36.82%
Holding current value
$352,936
Previous $478 Million
38.24%
% of portfolio
0.03%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding RGEN
# of Institutions
504Shares Held
58.7MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.13 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$982 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$755 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$285 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$241 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.25B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....